or Try an Advanced Search...

    Drug Therapies Stocks List

    Symbol Grade Name % Change
    KAPA C Kairos Pharma, Ltd. -16.37
    TKNO C Alpha Teknova, Inc. 5.45
    XBIO C Xenetic Biosciences, Inc. 0.00
    HROW D Harrow Health, Inc. 4.14
    ASND F Ascendis Pharma A/S 2.17
    CLSD F Clearside Biomedical, Inc. 0.00
    MRVI F Maravai LifeSciences Holdings, Inc. 0.66
    NLSP F NLS Pharmaceutics Ltd. -4.29
    PXMD F PaxMedica, Inc. -25.41
    View As Page of Charts
    Related Industries: Biotechnology Drug Manufacturers - Specialty & Generic
    Related Stock Lists: Biopharmaceutical Biotechnology Life Sciences Biology Biopharmaceutical Products Medicine Molecular Diagnostics Ophthalmology Pharmaceutical Products Pharmacy Acid Acute Myeloid Leukemia Adhd Adverum Biotechnologies Amphetamine Anemia Antibody Assay Development Services Attention Deficit Hyperactivity Disorder Autism Spectrum Disorder

    Related ETFs - A few ETFs which own one or more of the above listed Drug Therapies stocks.

    Symbol Grade Name Weight
    MEDI D Harbor Health Care ETF 17.04
    JFWD B Jacob Funds Inc. Jacob Forward ETF 7.97
    SYNB D Putnam BioRevolution ETF 3.64
    FFTY B Innovator IBD 50 Fund ETF 2.95
    PTH D Invesco DWA Healthcare Momentum ETF 2.36
    View all Drug Therapies ETFs...
    Compare ETFs
    Compare JFWD to SYNB Compare MEDI to FFTY Compare MEDI to SYNB

        Drug Therapies Stocks Recent News

        Date Stock Title
        Nov 18 NLSP NLS Pharmaceutics Highlights Innovative Preclinical Program for First-in-Class Non-Sulfonamide Dual Orexin Receptor Agonists (DOXA) in Narcolepsy and Neurological Disorders
        Nov 16 HROW Harrow: Spotlight On IHEEZO
        Nov 15 CLSD All You Need to Know About Clearside Biomedical (CLSD) Rating Upgrade to Buy
        Nov 15 HROW Harrow Announces Participation in Upcoming Investor Conferences
        Nov 15 CLSD Clearside Biomedical Third Quarter 2024 Earnings: Beats Expectations
        Nov 15 HROW Harrow Inc (HROW) Q3 2024 Earnings Call Highlights: Record Revenue and Strategic Growth Amid ...
        Nov 15 ASND Ascendis Pharma A/S (ASND) Q3 2024 Earnings Call Transcript
        Nov 14 ASND Ascendis Pharma GAAP EPS of -€1.72, revenue of €57.83M
        Nov 14 ASND Ascendis Pharma Reports Third Quarter 2024 Financial Results
        Nov 14 HROW Harrow, Inc. (HROW) Q3 2024 Earnings Call Transcript
        Nov 14 HROW Harrow, Inc. 2024 Q3 - Results - Earnings Call Presentation
        Nov 14 ASND (ASND) - Analyzing Ascendis Pharma's Short Interest
        Nov 14 HROW Why DLocal Shares Are Trading Higher By Around 18%; Here Are 20 Stocks Moving Premarket
        Nov 14 ASND Earnings Scheduled For November 14, 2024
        Nov 13 HROW Harrow stock plunges 20% on weaker-than-expected Q3 earnings
        Nov 13 ASND Ascendis Pharma Q3 2024 Earnings Preview
        Nov 13 HROW Harrow Health Non-GAAP EPS of -$0.05 misses by $0.12, revenue of $49.26M misses by $3.55M
        Nov 13 HROW Harrow Announces Third Quarter 2024 Financial Results
        Nov 13 HROW Harrow Launches Access and Affordability Program with Price Reductions for Branded Products
        Nov 13 KAPA Why Rocket Lab Shares Are Trading Higher By Around 29%; Here Are 20 Stocks Moving Premarket
        Related Industries: Biotechnology Drug Manufacturers - Specialty & Generic
        Related Stock Lists: Biopharmaceutical Biotechnology Life Sciences Biology Biopharmaceutical Products Medicine Molecular Diagnostics Ophthalmology Pharmaceutical Products Pharmacy Acid Acute Myeloid Leukemia Adhd Adverum Biotechnologies Amphetamine Anemia Antibody Assay Development Services Attention Deficit Hyperactivity Disorder Autism Spectrum Disorder
        Drug Therapies

        Drug therapies, also known as pharmacotherapy, are treatments that involve the use of medications to treat a variety of medical conditions. These medications can be used to treat physical illnesses, mental health disorders, and even addiction. Drug therapies can be used alone or in combination with other treatments, such as psychotherapy, to provide the best possible outcome for the patient.

        Browse All Tags